Entia Biosciences Company Executives
| ERGO Stock | USD 0.0002 0.00 0.00% |
Entia Biosciences employs about 6 people. The company is managed by 4 executives with a total tenure of roughly 25 years, averaging almost 6.0 years of service per executive, having 1.5 employees per reported executive. Analysis of Entia Biosciences' management performance can provide insight into the firm performance.
| Timothy Timmins President CFO, COO, Executive Vice President |
Entia |
Entia Biosciences Management Team Effectiveness
The company has return on total asset (ROA) of (1.6437) % which means that it has lost $1.6437 on every $100 spent on assets. This is way below average. Entia Biosciences' management efficiency ratios could be used to measure how well Entia Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Entia Biosciences Workforce Comparison
Entia Biosciences is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 553. Entia Biosciences claims roughly 6.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.
Entia Biosciences Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Entia Biosciences Price Series Summation is a cross summation of Entia Biosciences price series and its benchmark/peer.
Entia Biosciences Notable Stakeholders
An Entia Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Entia Biosciences often face trade-offs trying to please all of them. Entia Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Entia Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Timothy Timmins | CFO, COO, Executive Vice President | Profile | |
| Elliot Shelton | Secretary, Director | Profile | |
| Marvin MD | Chairman Officer | Profile | |
| William Meyer | Head Production | Profile |
About Entia Biosciences Management Performance
The success or failure of an entity such as Entia Biosciences often depends on how effective the management is. Entia Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Entia management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Entia management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon. Total Nutraceutical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
Entia Biosciences Workforce Analysis
Traditionally, organizations such as Entia Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Entia Biosciences within its industry.Entia Biosciences Manpower Efficiency
Return on Entia Biosciences Manpower
| Revenue Per Employee | 44.2K | |
| Revenue Per Executive | 66.4K | |
| Net Loss Per Employee | 232.6K | |
| Net Loss Per Executive | 348.9K |
Other Information on Investing in Entia Pink Sheet
Entia Biosciences financial ratios help investors to determine whether Entia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entia with respect to the benefits of owning Entia Biosciences security.